Market Indices
Sector Heatmap
PRQR — ProQR Therapeutics N.V. Ordinary Shares
NasdaqProQR Therapeutics N.V. Ordinary Shares
- O
- 1.63
- H
- 1.64
- L
- 1.60
- V
- 406K
PRQR — Latest News & Headlines
9 StoriesProQR Therapeutics N.V. (PRQR) Shareholder/Analyst Call - Slideshow (NASDAQ:PRQR) 2026-09-30 - Seeking Alpha
ProQR Therapeutics N.V. (PRQR) Shareholder/Analyst Call - Slideshow (NASDAQ:PRQR) 2026-09-30 Seeking Alpha
HC Wainwright Cuts ProQR Therapeutics (NASDAQ:PRQR) Price Target to $8.00 - MarketBeat
HC Wainwright Cuts ProQR Therapeutics (NASDAQ:PRQR) Price Target to $8.00 MarketBeat
PRQR Oct 2026 1.000 call (PRQR261016C00001000) Stock Price, News, Quote & History - Yahoo! Finance Canada
PRQR Oct 2026 1.000 call (PRQR261016C00001000) Stock Price, News, Quote & History Yahoo! Finance Canada
PRQR Maintained by Chardan Capital -- Price Target Holds at $3.0 - GuruFocus
PRQR Maintained by Chardan Capital -- Price Target Holds at $3.0 GuruFocus
Citizens reiterates ProQR stock rating on biliary atresia data - Investing.com
Citizens reiterates ProQR stock rating on biliary atresia data Investing.com
ProQR Therapeutics' (PRQR) "Buy" Rating Reiterated at Chardan Capital - MarketBeat
ProQR Therapeutics' (PRQR) "Buy" Rating Reiterated at Chardan Capital MarketBeat
Chardan Capital maintains Buy rating on ProQR Therapeutics, $3 price target - TradingView
Chardan Capital maintains Buy rating on ProQR Therapeutics, $3 price target TradingView
PRQR Maintains Rating by HC Wainwright & Co. -- Price Target Low - GuruFocus
PRQR Maintains Rating by HC Wainwright & Co. -- Price Target Low GuruFocus
FY2028 Earnings Estimate for PRQR Issued By HC Wainwright - MarketBeat
FY2028 Earnings Estimate for PRQR Issued By HC Wainwright MarketBeat